Cargando…

FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62

Frontotemporal lobar degeneration (FTLD) is a clinically, genetically, and neuropathologically heterogeneous group of neurodegenerative syndromes, leading to progressive cognitive dysfunction and frontal and temporal atrophy. C9orf72 hexanucleotide repeat expansion (C9-HRE) is the most common geneti...

Descripción completa

Detalles Bibliográficos
Autores principales: Leskelä, Stina, Hoffmann, Dorit, Rostalski, Hannah, Huber, Nadine, Wittrahm, Rebekka, Hartikainen, Päivi, Korhonen, Ville, Leinonen, Ville, Hiltunen, Mikko, Solje, Eino, Remes, Anne M., Haapasalo, Annakaisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599259/
https://www.ncbi.nlm.nih.gov/pubmed/34328616
http://dx.doi.org/10.1007/s12035-021-02475-x
_version_ 1784600909851918336
author Leskelä, Stina
Hoffmann, Dorit
Rostalski, Hannah
Huber, Nadine
Wittrahm, Rebekka
Hartikainen, Päivi
Korhonen, Ville
Leinonen, Ville
Hiltunen, Mikko
Solje, Eino
Remes, Anne M.
Haapasalo, Annakaisa
author_facet Leskelä, Stina
Hoffmann, Dorit
Rostalski, Hannah
Huber, Nadine
Wittrahm, Rebekka
Hartikainen, Päivi
Korhonen, Ville
Leinonen, Ville
Hiltunen, Mikko
Solje, Eino
Remes, Anne M.
Haapasalo, Annakaisa
author_sort Leskelä, Stina
collection PubMed
description Frontotemporal lobar degeneration (FTLD) is a clinically, genetically, and neuropathologically heterogeneous group of neurodegenerative syndromes, leading to progressive cognitive dysfunction and frontal and temporal atrophy. C9orf72 hexanucleotide repeat expansion (C9-HRE) is the most common genetic cause of FTLD, but pathogenic mechanisms underlying FTLD are not fully understood. Here, we compared cellular features and functional properties, especially related to protein degradation pathways and mitochondrial function, of FTLD patient–derived skin fibroblasts from C9-HRE carriers and non-carriers and healthy donors. Fibroblasts from C9-HRE carriers were found to produce RNA foci, but no dipeptide repeat proteins, and they showed unchanged levels of C9orf72 mRNA transcripts. The main protein degradation pathways, the ubiquitin–proteasome system and autophagy, did not show alterations between the fibroblasts from C9-HRE-carrying and non-carrying FTLD patients and compared to healthy controls. An increase in the number and size of p62-positive puncta was evident in fibroblasts from both C9-HRE carriers and non-carriers. In addition, several parameters of mitochondrial function, namely, basal and maximal respiration and respiration linked to ATP production, were significantly reduced in the FTLD patient–derived fibroblasts from both C9-HRE carriers and non-carriers. Our findings suggest that FTLD patient–derived fibroblasts, regardless of whether they carry the C9-HRE expansion, show unchanged proteasomal and autophagic function, but significantly impaired mitochondrial function and increased accumulation of p62 when compared to control fibroblasts. These findings suggest the possibility of utilizing FTLD patient–derived fibroblasts as a platform for biomarker discovery and testing of drugs targeted to specific cellular functions, such as mitochondrial respiration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-021-02475-x.
format Online
Article
Text
id pubmed-8599259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85992592021-11-24 FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62 Leskelä, Stina Hoffmann, Dorit Rostalski, Hannah Huber, Nadine Wittrahm, Rebekka Hartikainen, Päivi Korhonen, Ville Leinonen, Ville Hiltunen, Mikko Solje, Eino Remes, Anne M. Haapasalo, Annakaisa Mol Neurobiol Article Frontotemporal lobar degeneration (FTLD) is a clinically, genetically, and neuropathologically heterogeneous group of neurodegenerative syndromes, leading to progressive cognitive dysfunction and frontal and temporal atrophy. C9orf72 hexanucleotide repeat expansion (C9-HRE) is the most common genetic cause of FTLD, but pathogenic mechanisms underlying FTLD are not fully understood. Here, we compared cellular features and functional properties, especially related to protein degradation pathways and mitochondrial function, of FTLD patient–derived skin fibroblasts from C9-HRE carriers and non-carriers and healthy donors. Fibroblasts from C9-HRE carriers were found to produce RNA foci, but no dipeptide repeat proteins, and they showed unchanged levels of C9orf72 mRNA transcripts. The main protein degradation pathways, the ubiquitin–proteasome system and autophagy, did not show alterations between the fibroblasts from C9-HRE-carrying and non-carrying FTLD patients and compared to healthy controls. An increase in the number and size of p62-positive puncta was evident in fibroblasts from both C9-HRE carriers and non-carriers. In addition, several parameters of mitochondrial function, namely, basal and maximal respiration and respiration linked to ATP production, were significantly reduced in the FTLD patient–derived fibroblasts from both C9-HRE carriers and non-carriers. Our findings suggest that FTLD patient–derived fibroblasts, regardless of whether they carry the C9-HRE expansion, show unchanged proteasomal and autophagic function, but significantly impaired mitochondrial function and increased accumulation of p62 when compared to control fibroblasts. These findings suggest the possibility of utilizing FTLD patient–derived fibroblasts as a platform for biomarker discovery and testing of drugs targeted to specific cellular functions, such as mitochondrial respiration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12035-021-02475-x. Springer US 2021-07-30 2021 /pmc/articles/PMC8599259/ /pubmed/34328616 http://dx.doi.org/10.1007/s12035-021-02475-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Leskelä, Stina
Hoffmann, Dorit
Rostalski, Hannah
Huber, Nadine
Wittrahm, Rebekka
Hartikainen, Päivi
Korhonen, Ville
Leinonen, Ville
Hiltunen, Mikko
Solje, Eino
Remes, Anne M.
Haapasalo, Annakaisa
FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
title FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
title_full FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
title_fullStr FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
title_full_unstemmed FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
title_short FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
title_sort ftld patient–derived fibroblasts show defective mitochondrial function and accumulation of p62
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599259/
https://www.ncbi.nlm.nih.gov/pubmed/34328616
http://dx.doi.org/10.1007/s12035-021-02475-x
work_keys_str_mv AT leskelastina ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT hoffmanndorit ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT rostalskihannah ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT hubernadine ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT wittrahmrebekka ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT hartikainenpaivi ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT korhonenville ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT leinonenville ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT hiltunenmikko ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT soljeeino ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT remesannem ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62
AT haapasaloannakaisa ftldpatientderivedfibroblastsshowdefectivemitochondrialfunctionandaccumulationofp62